Office of Professional Education

October 12-15, 2017 | Warwick Denver Hotel in Denver, CO

Call for Abstracts | Submissions are closed.

To be notified when the Call for Abstracts opens for the 2018 Respiratory Disease Young Investigators' Forum, please email your contact information to

Please click on the following topics for more information:


The Thirteenth Annual Respiratory Disease Young Investigators’ Forum is a unique educational opportunity designed specifically for US-based Fellows (MDs, DOs) actively enrolled in a pulmonary, allergy, or immunology fellowship program during the 2016-2017 academic year who are conducting research on airway diseases, including asthma, chronic obstructive pulmonary disease, cystic fibrosis, interstitial lung disease, pulmonary fibrosis, pulmonary vascular disease, lung transplant, allergic rhinitis, genetics of airway diseases, or bronchiectasis, in either pediatric or adult populations. Young investigators who are transitioning to initial faculty positions following the completion of their fellowship training in June 2017 are especially encouraged to participate.

Eligible Fellows are invited to submit an abstract of their research (clinical or basic science) to a panel of 9 expert faculty for assessment. The abstracts are blinded, and each one is scored by the expert faculty. Based on these scores, the top 30 abstracts are accepted (15 clinical research and 15 basic science research). It should be noted that the final selection of abstracts is based on the quality of the research and the number of abstracts received in each category.The top 30 young investigators are invited to attend the Forum as presenting faculty to present their research in full for further review and comments by the expert faculty and peer presenting faculty. Based on the scores of the expert faculty, the top 3 presenters in each category noted above will be provided with a monetary award and a plaque.

During the Forum, additional group discussions with expert faculty will be planned. At the conclusion of the activity, participants should be able to:

  • Identify new areas of respiratory research that offer new inroads to effective therapies
  • Identify the key components to be included in respiratory basic science and clinical research
  • Discuss research study designs that may improve on current approaches to respiratory research
  • Identify strengths and weaknesses of the research and receive constructive input on the studies presented

Top of Page

Program Information

Abstract Submission Deadline:

All abstracts must be received by midnight PST, June 30, 2017. Submit abstracts via email to


  • US-based pulmonary, allergy, and/or immunology Fellows (MDs and DOs), with or without PhD degrees, involved in research related to airway diseases such as asthma, COPD, cystic fibrosis, or bronchiectasis are eligible.
  • Fellows enrolled in basic or clinical research programs during the 2016-2017 academic year. Young investigators transitioning to initial faculty positions following completion of their fellowship training in June 2017 are especially encouraged to participate.
  • PhD-only research Fellows are not eligible.
  • Candidates must be based in the United States (training must be completed at a US-based institution).
  • All work must be unpublished original research in an area related to lung diseases. Publication as an abstract alone does not preclude eligibility; however, an abstract will not be accepted if it has been published as an article before October 1, 2017. Abstracts/papers to be presented at future medical meetings are eligible for submission.

Abstracts: Policies and Procedures:

Only 1 abstract submission per Fellow will be accepted. Abstracts must conform exactly to the abstract preparation instructions. Those that do not may be rejected. No revisions to submitted abstracts will be accepted. Only original work done by the Fellow will be accepted.

Selection Process:

Submission deadline is midnight PST, on Friday, June 30, 2017. Monica Kraft, MD and the expert faculty will review all submissions. All accepted abstracts will be published in a program workbook. The publication of this workbook will not preclude publication or presentation elsewhere. Presentations will be podium format and will consist of a formal presentation and question-and-answer period.


The 30 finalists (authors of accepted abstracts) will be provided with the following: One (1) roundtrip, economy-class ticket from their city of origin to Denver. Reimbursement for ground transfers to and from the program hotel in Denver. 3 nights’ lodging (Thursday, Friday, and Saturday) at the program hotel. All group buffet meals (breakfast, lunch, and dinner) for the duration of the program.


An awards ceremony will be held on Saturday evening, October 14, 2017, at which the award winners in each of the 2 categories (basic science and clinical) for first prize ($1500/recipient), second prize ($1000/recipient), and third prize ($500/recipient) will be announced.

Top of Page

Instructions for Abstract Preparation and Submission


Your submission MUST include the following information:

  • Full Name, degree(s)
  • Mailing address (no PO Boxes)
  • Daytime telephone, fax, pager, e-mail address,
  • Current institution (where fellowship is being conducted)
  • Previous institution (where research was conducted, if applicable)
  • Year of fellowship (1, 2, 3)
  • Study type: Basic Science or Clinical Research


Title and Author: Abstracts should consist of a brief title (bold, Initial Capitals) descriptive of the research. Include first and last names and degrees of the authors. Underline the presenting author’s name and list the name and location of the institution where research was completed. Do not identify authors in the body of the abstract. 

Text: Abstract text must be 500 words or fewer. Sans serif font (such as Arial or Helvetica) is preferred. Do not use font sizes smaller than 10 point.  

Figures and Tables:  Please make sure all figures are high resolution (at least 300 dpi).No more than a total of 4 figures and/or tables per submission are permitted. Please limit figures to 1 graph or image each (ie, no multiple-part figures). All figures will be printed in black and white. Please keep this in mind and adjust your figures and legends accordingly. Legends should be included with figures and are not included in the 500-word limit; figures should be embedded in the abstract file and not included as separate e-mail attachments.


Organize the body of the abstract in the following manner:
a. Disclosure of relevant financial relationships (not included in word count).
b. A sentence stating the purpose of the study, unless stated in the title
c. A brief statement of methods, if pertinent.
d. A summary of results
e. A statement of conclusions reached. It is not satisfactory to state, “The results will be discussed.”

Submission VIA EMAIL:

Forward an e-mail with the abstract attached as a Microsoft Word Version 2003 or later document to:

All identification information listed herein MUST be included at the top of your abstract. Abstracts that do not have complete identification information may not be accepted. The subject line of your e-mail must read: “Your Last Name, YIF2017.” Submission deadline is midnight PST, on Friday, June 30, 2017.


  • Abstract Receipt: Notification of abstract receipt will be provided to you via e-mail.
  • Abstract Acceptance: Notification of abstract acceptance or rejection will be provided to you via e-mail in July 2017.

Top of Page


  • Monica Kraft, MD, Co-Chair
  • Irina Petrache, MD, Co-Chair
  • Gregory P. Downey, MD
  • Jay Kolls, MD
  • Stephen C. Lazarus, MD
  • Reynold A. Panettieri, Jr, MD
  • Ramana Sidhaye, MD
  • Lewis J. Smith, MD
  • Mihaela Teodorescu, MD, MS

Top of Page

Credit Desgination and Compliance

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education by National Jewish Health. National Jewish Health is accredited by the ACCME to provide continuing medical education for physicians.

National Jewish Health designates this live activity for a maximum of 10 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Top of Page


If you need additional information or would like copies of the “Call for Abstracts” brochure, please contact Mandy Comeau of National Jewish Health, at 303.728.6585 or

Top of Page

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP.